Michelle Finn
About Michelle Finn
Michelle Finn is the Director of US Gastroenterology Marketing for Zeposia at Bristol Myers Squibb in Summit, New Jersey. She has extensive experience in marketing and financial analysis, having previously worked at Celgene, Coviden, and Johnson & Johnson.
Current Role and Responsibilities
Michelle Finn is currently serving as the Director of US Gastroenterology Marketing for Zeposia at Bristol Myers Squibb (BMS) in Summit, New Jersey, United States. In this role, she provides strategic commercial direction for pipeline assets in gastroenterology, guiding marketing efforts to support the launch and growth of Zeposia. Her current responsibilities involve leveraging her extensive background in pharmaceutical marketing to ensure effective market penetration and commercial success.
Previous Experience at Bristol Myers Squibb
Prior to her current role, Michelle Finn worked as Director of Global Immunology Commercial Development at Bristol Myers Squibb from 2019 to 2021. During these two years, she played a critical role in shaping global commercial strategies for immunology products. Her expertise was pivotal in guiding the commercial development of pipeline assets across various therapeutic areas including dermatology, rheumatology, and gastroenterology.
Marketing Roles at Celgene
Michelle Finn's professional journey at Celgene involved several key marketing positions. She served as Director, Chief of Staff, Inflammation & Immunology (2018-2019) and Associate Director, Consumer/Patient Marketing, Inflammation & Immunology (2018). Additionally, she was Associate Director, US Dermatology Marketing for Otezla (2017-2018) and Senior Product Manager, US Rheumatology Marketing for Otezla (2016-2017). Across these roles, she focused on developing and executing marketing strategies to drive product adoption and growth within inflammation, immunology, dermatology, and rheumatology sectors.
Financial Analysis Background
Michelle Finn also possesses a strong background in financial analysis and planning. She worked as a Senior Financial Analyst in Financial Planning & Analysis at Coviden (now Medtronic) from 2010 to 2012 in Boulder, Colorado. Before Coviden, she held roles at Johnson & Johnson where she served as a Senior Financial Analyst in Operations & Project Finance (2008-2009) and as a Financial Analyst in the Financial Leadership Development Program from 2006 to 2008. These positions equipped her with robust financial management skills that have complemented her marketing roles.
Educational Background
Michelle Finn holds a Master of Business Administration (M.B.A.) in Pharmaceutical Management & Marketing Research Insights and Analytics from Rutgers Business School, where she studied from 2012 to 2014. She also earned a Bachelor's Degree in Business Administration from The College of New Jersey, completing her studies in three years from 2002 to 2005. Her educational background has provided a strong foundation for her career in pharmaceutical marketing and financial analysis.